New High, page-196

I’m sure your right about the company needing to step up to it. I’ve seen a lot of med research. Just about every phase. I saw a professor talk a company into doing an expensive trial that affected only a small patient group once. That coy broke. I see doctors who are genuinely enthusiastic but not thinking about the commercial side. And pharma that spin a story on not that convincing research and talk up the product massively. Lct are quiet. What do hey want to do. We going to come back in 5 yrs and find big pharma into livestock. Like Whyte asked how many piglets per patient. What is the scalability. When they use it for Alzheimer’s there are going to be so many pigs, & wot happens when they herd gets sick? Maybe it’s cloned tissue, don’t need a herd. They should be talking it up, wit there plans are for after the positive trial result. But maybe they just be looking for a buyer. And wot when the imam is treated without understanding the product